DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hsu C-Y, Shen Y-C, Yu C-W. , et al.
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
J Hepatol 2011;
55 (04) 858-865
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.